Navigation Links
New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography
Date:6/1/2009

New Merck KGaA Study Reveals Wide Variations in Therapy Regimens, with Monotherapy Most Common in Elderly Patients and Triplets Most Prevalent in the US

ORLANDO, Fla., June 1 /PRNewswire/ -- There are striking differences in treatment regimens for non-small cell lung cancer (NSCLC) patients, based on both age and geography, according to a new market research study conducted by Merck KGaA, Darmstadt, Germany, presented as a poster on Saturday at the 2009 ASCO (American Society of Clinical Oncology) meeting in Orlando, Florida (Abstract no.: 8053; Poster no.: N15). Performed in conjunction with TNS Healthcare, the representative study shows that among patients with advanced NSCLC, monotherapy is used most often among those 70 or older, while combination therapies are administered most frequently to younger patients. Location also is a key factor in determining therapy choice, with a chemotherapy doublet plus a targeted agent far more common in the US than in Europe.

"While chemotherapy doublets remain the standard regimen for first-line treatment of stage IIIB and IV NSCLC, there are substantial differences among regions in the doublets most often chosen and whether a targeted agent is concurrently administered," says J.F. Vansteenkiste, first author of the poster. "For example, the preferred doublet in Europe is platinum plus gemcitabine, used in 29% of patients. In contrast, in the US and Japan, platinum plus taxanes is predominant, used in more than a quarter of American and more than half of Japanese patients."

"The most extensive use of doublets plus targeted agent is in the US, in contrast with Europe and Japan. Almost half of non-squamous cancer patients younger than 70 are being treated with these combinations in the US. Even among those older than 70, more than a quarter of patients are on chemotherapy doublets plus targeted agent." Randomized phase III studies have shown that adding targeted agents to standard first-line treatments can prolong overall survival.

Almost 5,000 NSCLC Patients Monitored

Merck KGaA already had presented at last year's ASCO a landmark study for Erbitux in combination with standard 1st-line chemotherapy in advanced NSCLC which showed for the first time in 10 years a significant survival benefit in a broad patient population. In the current study Merck KGaA monitored 4,950 patients from May to mid-July 2008 across Western Europe (Spain, Italy, Germany, France and the UK), the US and Japan. TNS Healthcare recruited oncologists in the US, oncologists, radiotherapists and pulmonologists in Europe and pulmonologists and respiratory surgeons in Japan to participate. Physicians who contributed provided information through on-line patient record forms.

About Merck...

Merck is a global pharmaceutical and chemical company with total revenues of euro 7.6 billion in 2008, a history that began in 1668, and a future shaped by 32,700 employees in 60 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

About TNS Healthcare...

TNS Healthcare provides market research consulting to the worldwide pharmaceutical, biotech and medical device industries, as well as health-focused ad agencies, media and analysts. It offers globally consistent solutions and custom advisory services to support product introductions; brand, treatment and sales performance optimization; and physician and DTC promotional assessment.

Informing decisions across the life cycle, TNS Healthcare offers action-ready insights for pre- launch landscaping, market and opportunity assessment, segmentation, positioning, message and campaign creation, pricing, forecasting, attitude and awareness measurement and post-launch tracking. It delivers information across stakeholders--including physicians, patients and consumers--to help companies anticipate and impact customers' behaviors. TNS Healthcare provides both qualitative and quantitative offerings, using traditional and on- line methodologies, combining worldwide reach with local expertise.

For more information, visit www.tnsglobal.com/healthcare.


'/>"/>
SOURCE TNS Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nuvilex Launches Video Marketing Campaign
2. Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization
3. Amgens Denosumab and Eli Lillys Forteo/Forsteo Will Drive Robust Annual Growth in the Osteoporosis Drug Market From 2013 to 2018
4. Practice-Reps Brings Sales and Marketing to the Business of Medical Practice Management
5. SAFC(R) & Cherokee Pharmaceuticals(TM) Pool Expertise and Resources With Strategic Partnership For U.S. Market
6. Clearly Contacts Forms Strategic Marketing Alliance with Stockhouse
7. Avantpage Translations Releases White Paper on Capturing The Fastest Growing Healthcare Market In America
8. The Female Health Company Switches to the NASDAQ Stock Market
9. Although the Health Care Market is Recession-Resistant, It Is Not Recession-Immune, According to Millennium Research Groups Medtech Economic Quarterly Publication
10. Astellas Announces New Vice President of Marketing
11. Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium ... Master File solutions, today—from the IQPC Trial Master ... , NL)—announced that EastHORN Clinical Services has ... clinical programs and TMF management. EastHORN, a leading ... eTMF platform to increase transparency to enable greater ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: